Post-earnings recap
Reported
Thu, Nov 3, 2022
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
75%
Moderna's earnings report shows a significant miss on EPS, which contributed to a slight decline in the stock price by 0.75%. The lack of revenue data and management commentary leaves investors with limited insight into the company's future performance. Overall, the results indicate potential concerns about profitability in the current market environment.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.53 | N/A | -16.69% |
| Revenue | N/A | N/A | N/A |
No transcript is on record for the earnings call, so the analysis is based solely on numerical results.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—